COA Conference Coverage
Featured Articles
(AJMC Managed Markets Network) Apr 5, 2019 - The first day of the 2019 Community Oncology Conference, the major annual meeting of the Community Oncology Alliance (COA), featured an update on its effort to find alternatives to CMS' Oncology Care Model. After a year in development, the Community Oncology Alliance (COA) will file its...
Read Article
Latest Articles
April 08, 2019
April 05, 2019

OBR Tweets

Jun 04
Thierry Andre, MD, of @SorbonneTest regarding the outcomes of the Keynote-177 study in metastatic colorectal cancer… https://t.co/RHq8srk1Tp

Jun 04
Matthew Galsky @MattGalsky, MD, of @TischCancer of Medicine shares the design and outcomes of the Javelin Bladder 1… https://t.co/jGF449A8WV

Jun 04
Thomas Marsland, MD: As a Conquer Cancer board member I am extremely proud of our support for cutting edge research… https://t.co/GZsCunoBdt

Jun 03
Bruce Feinberg, DO, of @cardinalhealth on the understanding medical oncologists have on social determinants of heal… https://t.co/vljJrCSY2s

Jun 03
Joyce Liu, MD, of @harvardmed summarizes outcomes of the NRG-GY004 phase III study regarding ovarian cancer #ASCO20 https://t.co/AMgQIwd3R3

Jun 03
Shaji Kumar @myelomaMD, MD, of @MayoClinic shares results of the Phase 3 study regarding 1st line multiple myeloma… https://t.co/22ZqeOQRoc

Jun 03
Roy Herbst, MD, PhD, of @YaleCancer shares perspective on the plenary session presentation of the ADAURA study… https://t.co/ci27SPnIGn

Jun 03
Xiuning Le @LeXiuning, MD, PhD, of @MDAndersonNews discusses goals and results of the VISION study in non-small ce… https://t.co/TGf3v3nzDi

Jun 02
Jorge Cortes @GCC_Cortes, MD, of @GACancerCenter on the evolution of CAR-T cell therapies in hematologic malignanci… https://t.co/GM4S2vb9bd

Jun 02
Salvatore Sienna, MD, of @LaStatale on what is next for Enhertu (trastuzumab deruxtecan) in clinical development… https://t.co/M5eqKkvNUH